HQL · abrdn Life Sciences Investors · Fund Holdings
Market Cap
$649.82M
Shares
30.41M
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
abrdn Life Sciences Investors
Reported 2026-06-30Net Assets
$689,248,803
Total Assets
$690,887,804
Holdings
158
Filed
2026-08-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| uniQure NV | 000000000 | 564,239 | NS | $25,988,848 | 3.77% | EC | NL |
| Insmed Inc | 457669307 | 208,079 | NS | $22,185,383 | 3.22% | EC | US |
| VeraDermics Inc | 922967104 | 171,383 | NS | $21,069,826 | 3.06% | EC | US |
| Personalis Inc | 71535D106 | 1,542,774 | NS | $20,673,172 | 3.00% | EC | US |
| Argenx SE | 04016X101 | 19,643 | NS | $18,224,186 | 2.64% | EC | NL |
| Dyne Therapeutics Inc | 26818M108 | 799,847 | NS | $17,764,602 | 2.58% | EC | US |
| Denali Therapeutics Inc | 24823R105 | 658,067 | NS | $16,925,483 | 2.46% | EC | US |
| VERADERMICS, INC. | 000000000 | 109,305 | NS | $13,437,957 | 1.95% | EP | US |
| Abivax SA | 00370M103 | 98,044 | NS | $13,065,343 | 1.90% | EC | FR |
| Immunovant Inc | 45258J102 | 337,211 | NS | $12,992,740 | 1.89% | EC | US |
| Tectonic Therapeutic Inc | 878972108 | 370,884 | NS | $12,749,138 | 1.85% | EC | US |
| Crinetics Pharmaceuticals Inc | 22663K107 | 312,153 | NS | $11,680,765 | 1.69% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 122,702 | NS | $11,677,549 | 1.69% | EC | US |
| Equillium Inc | 29446K106 | 3,631,659 | NS | $11,621,309 | 1.69% | EC | US |
| NEUROVANCE MILESTONE INTEREST | 000000000 | 34,055 | NS | $11,413,530 | 1.66% | EC | US |
| Edgewise Therapeutics Inc | 28036F105 | 264,002 | NS | $10,726,401 | 1.56% | EC | US |
| Axsome Therapeutics Inc | 05464T104 | 43,454 | NS | $10,636,236 | 1.54% | EC | US |
| Xenon Pharmaceuticals Inc | 98420N105 | 170,859 | NS | $10,313,049 | 1.50% | EC | CA |
| Taysha Gene Therapies Inc | 877619106 | 1,496,652 | NS | $10,192,200 | 1.48% | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | 30,409 | NS | $10,180,629 | 1.48% | EC | US |
| EyePoint Inc | 30233G209 | 710,173 | NS | $10,155,474 | 1.47% | EC | US |
| Shattuck Labs Inc | 82024L103 | 1,405,851 | NS | $9,756,606 | 1.42% | EC | US |
| Summit Therapeutics Inc | 86627T108 | 630,806 | NS | $9,190,843 | 1.33% | EC | US |
| BioCryst Pharmaceuticals Inc | 09058V103 | 898,336 | NS | $8,983,360 | 1.30% | EC | US |
| Disc Medicine Inc | 254604101 | 121,484 | NS | $8,885,340 | 1.29% | EC | US |
| Structure Therapeutics Inc | 86366E106 | 162,217 | NS | $8,706,186 | 1.26% | EC | KY |
| Precision BioSciences Inc | 74019P207 | 1,085,970 | NS | $8,535,724 | 1.24% | EC | US |
| Arrowhead Pharmaceuticals Inc | 04280A100 | 104,478 | NS | $8,516,002 | 1.24% | EC | US |
| Ionis Pharmaceuticals Inc | 462222100 | 106,455 | NS | $8,440,817 | 1.22% | EC | US |
| Ideaya Biosciences Inc | 45166A102 | 222,056 | NS | $8,276,027 | 1.20% | EC | US |
| Newamsterdam Pharma Co NV | 000000000 | 244,176 | NS | $8,275,125 | 1.20% | EC | NL |
| Revolution Medicines Inc | 76155X100 | 43,763 | NS | $8,195,935 | 1.19% | EC | US |
| Syndax Pharmaceuticals Inc | 87164F105 | 372,766 | NS | $8,148,665 | 1.18% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 428,795 | NS | $7,705,446 | 1.12% | EC | US |
| Adaptive Biotechnologies Corp | 00650F109 | 344,653 | NS | $7,392,807 | 1.07% | EC | US |
| Vaxcyte Inc | 92243G108 | 126,674 | NS | $7,363,560 | 1.07% | EC | US |
| Tempus AI Inc | 88023B103 | 124,615 | NS | $7,218,947 | 1.05% | EC | US |
| State Street Global Advisors | 857492706 | 6,953,413 | NS | $6,953,413 | 1.01% | STIV | US |
| IMMUNIC | 000000000 | 444,460 | NS | $6,831,356 | 0.99% | DE | US |
| Sagimet Biosciences Inc | 786700104 | 847,700 | NS | $6,552,721 | 0.95% | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | 10,241 | NS | $6,385,673 | 0.93% | EC | US |
| Palvella Therapeutics Inc | 697947109 | 40,805 | NS | $6,235,820 | 0.90% | EC | US |
| Vericel Corp | 92346J108 | 135,240 | NS | $6,016,828 | 0.87% | EC | US |
| Allogene Therapeutics Inc | 019770106 | 2,731,752 | NS | $5,682,044 | 0.82% | EC | US |
| Amgen Inc | 031162100 | 15,306 | NS | $5,542,609 | 0.80% | EC | US |
| Biohaven Ltd | 000000000 | 365,519 | NS | $5,438,923 | 0.79% | EC | VG |
| GRAIL Inc | 384747101 | 77,618 | NS | $5,298,981 | 0.77% | EC | US |
| Codexis Inc | 192005106 | 2,336,234 | NS | $5,279,889 | 0.77% | EC | US |
| ARS Pharmaceuticals Inc | 82835W108 | 651,538 | NS | $5,218,819 | 0.76% | EC | US |
| Amylyx Pharmaceuticals Inc | 03237H101 | 285,776 | NS | $5,132,537 | 0.74% | EC | US |
Showing 1–50 of 158 holdings
Key facts
CIK
884121
CUSIP
87911K100
13F (30d)
18 filings
18 filers